Kodiak Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KOD research report →
About the company
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer.
- CEO
- Victor Perlroth
- IPO
- 2018
- Employees
- 109
- HQ
- Palo Alto, CA, US
Price Chart
- Market Cap
- $2.04B
- P/E
- -9.24
- P/S
- 0.00
- P/B
- 21.27
- EV/EBITDA
- -10.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -253.85%
- ROIC
- -87.69%
- Revenue
- $0 · 0.00%
- Net Income
- $-229,967,000 · -30.51%
- EPS
- $-4.32 · -28.96%
- Op Income
- $-234,388,000
- FCF YoY
- -15.97%
- 52W High
- $47.84
- 52W Low
- $3.70
- 50D MA
- $37.79
- 200D MA
- $27.60
- Beta
- 2.20
- Avg Volume
- 773.60K
Get TickerSpark's AI analysis on KOD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Yang Taiyin | other | 17,731 |
| Jun 30, 26 | PROFUSEK ROBERT | other | 17,731 |
| Jun 30, 26 | Levy Richard S | other | 17,731 |
| Jun 30, 26 | Dahiyat Bassil I | other | 17,731 |
| Jun 30, 26 | Bancroft Charles A | other | 17,731 |
| Jun 30, 26 | BAKER BROS. ADVISORS LP | other | 17,731 |
| Jun 4, 26 | BORGESON JOHN A. | other | 30,000 |
| Jun 4, 26 | BORGESON JOHN A. | sell | 25,896 |
| Jun 4, 26 | BORGESON JOHN A. | sell | 4,104 |
| Jun 4, 26 | BORGESON JOHN A. | other | 30,000 |
Our KOD coverage
Recent articles, reports, and earnings notes.
No research on KOD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KOD report →Similar companies
Peers in the same neighborhood.